| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/22/2011 | CN102100777A Medicinal liquor for treating stroke sequela |
| 06/22/2011 | CN102100774A Green and natural Chinese medicine powder for foot bath and health care |
| 06/22/2011 | CN102100771A Capsules for treating haemorrhoids |
| 06/22/2011 | CN102100770A Traditional Chinese medicine preparation for treating hyperlipidemia |
| 06/22/2011 | CN102100763A Preparation technology of new integrative formulation of counterflow decoction and production method thereof |
| 06/22/2011 | CN102100755A Preparation technology of integrated ephedra, aconite and asarum decoction novel dosage form |
| 06/22/2011 | CN102100743A Quality control method for hypotensive pathogenic wind dispelling tablets |
| 06/22/2011 | CN102100742A Water-solubility extract of root of red-rooted salvia, preparation method thereof and application thereof |
| 06/22/2011 | CN102100741A Total tanshinone composite preparation |
| 06/22/2011 | CN102100740A Technology for preparing integrated novel formulation of compound root of red-rooted salvia formula and production method thereof |
| 06/22/2011 | CN102100739A Chinese medicinal composition containing salvianic acid A and pseudoginseng root saponin R1 and application thereof |
| 06/22/2011 | CN102100738A Application of compound danshen dripping pills in preparation of medicines for treating microcirculation disturbance and myocardial fibrosis |
| 06/22/2011 | CN102100737A Medicinal composition containing general ginsenoside and total salvianolic acid and preparation method thereof |
| 06/22/2011 | CN102100736A Method for simultaneously extracting water-soluble and lipid-soluble effective components in traditional Chinese medicine salvia miltiorrhiza bunge |
| 06/22/2011 | CN102100731A Novel application of astragalus mongholicus saponins extract and preparation method thereof |
| 06/22/2011 | CN102100725A Preparation technology of extracting total alkaloid extraction from Gansu whin |
| 06/22/2011 | CN102100722A Chrysanthemum morifolium ramat general flavone pill and preparation method thereof |
| 06/22/2011 | CN102100721A Method for producing total flavonoids of chrysanthemum |
| 06/22/2011 | CN102100712A Method for extracting panax notoginseng saponins by using continuous countercurrent ultrasonic extraction combined film technology |
| 06/22/2011 | CN102100711A Application of pseudoginseng root total saponins and preparations thereof in adjuvant treatment of 'systemic inflammatory response syndrome' |
| 06/22/2011 | CN102100707A Cordyceps sinensis health-care liquor |
| 06/22/2011 | CN102100704A Composition of probiotic strain GM-080 for treating carditis and heart apoptosis and application thereof |
| 06/22/2011 | CN102100703A Formula for treating haemorrhoids |
| 06/22/2011 | CN102100699A Composition of coral calcium hydroxide and arginine and application thereof |
| 06/22/2011 | CN102100698A New clinical use of pharmaceutical composition |
| 06/22/2011 | CN102100695A High-safety medicinal composition of cinepazide, and preparation method and application thereof |
| 06/22/2011 | CN102100680A Benazepril hydrochloride pulse-released tablet and preparation method thereof |
| 06/22/2011 | CN102100665A Eye drops containing vitamin E derivatives and preparation method thereof |
| 06/22/2011 | CN102100459A Chinese herbal medicine bamboo charcoal healthcare mattress and preparation method thereof |
| 06/22/2011 | CN101836993B Application of 2,3-dihydrogen-3-hydroxymethyl-6-amino-[1,4]-benzoxazine in preparing medicaments for inducing embryonic stem cells to differentiate towards vascular endothelial cells |
| 06/22/2011 | CN101780249B Traditional Chinese medicine composition for treating stroke hemiplegia and preparation method thereof |
| 06/22/2011 | CN101756915B Tirofiban hydrochloride lyophilized powder injection and preparation method thereof |
| 06/22/2011 | CN101732687B Methyldopa-containing medicament |
| 06/22/2011 | CN101732491B Medicament for treating hypertension, hyperlipoidemia, high blood viscosity and anti-aging |
| 06/22/2011 | CN101721585B Medicine for treating coronary disease and preparation thereof |
| 06/22/2011 | CN101716150B Acehytisine freeze-drying emulsion and reparation method thereof |
| 06/22/2011 | CN101708326B Medicine containing nifedipine |
| 06/22/2011 | CN101708157B Isosorbide mononitrate sodium chloride injection |
| 06/22/2011 | CN101695475B Ozagrel sodium injection and preparation method thereof |
| 06/22/2011 | CN101693068B Medicament for lowering blood pressure and blood lipid |
| 06/22/2011 | CN101669904B Epoprostanol lipid nanoparticle and preparation method thereof |
| 06/22/2011 | CN101633645B N3 alkylated benzimidazole derivatives as mek inhibitors |
| 06/22/2011 | CN101618128B Medicine for treating hemorrhoid and preparation method thereof |
| 06/22/2011 | CN101612316B Application of dendrobium officinale aqueous extract in preparing medicine for preventing and treating hypertension and apoplexy |
| 06/22/2011 | CN101584799B Medicament for treating angina pectoris |
| 06/22/2011 | CN101538293B Method for preparing secoisolariciresinol diglucoside and ferulic acid glucoside or ferulic acid glucoside ethyl ester |
| 06/22/2011 | CN101537101B Drug used for curing liver, limb muscles and pelvic blood vessel tumors and complicating diseases thereof, varicosity of leg and ulcer with hemorrhage and a preparation method thereof |
| 06/22/2011 | CN101463022B Preparation of Chinese medicine Yulansan chalcone monomer and use thereof |
| 06/22/2011 | CN101439163B Chinese medicine for radically treating hemorrhoid |
| 06/22/2011 | CN101406504B Method for extracting flavone substances in jumi |
| 06/22/2011 | CN101332227B Preparation method of Clary injection |
| 06/22/2011 | CN101265484B Method for constructing pacing channel gene hypotype HCN2 recombination slow virus vector |
| 06/22/2011 | CN101175758B Anhydrous crystalline forms of n-[1-(2-ethoxyethyl)-5-(n-ethyl-n-methylamino)-7-(4-methylpyridin-2-yl-amino)-1h-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide |
| 06/22/2011 | CN101167787B Albizzia plant extraction composition for inhibiting angiogenesis and preparation and application thereof |
| 06/22/2011 | CN101130061B Segmented intestine targeted drug feeding preparation of myocardium protein polypeptide and method of producing the same |
| 06/22/2011 | CN101120949B Traditional Chinese medicine for treating haemorrhoids |
| 06/22/2011 | CN101120789B Method for producing instant powder of cactus |
| 06/22/2011 | CN101108847B (+) doxazosin mesylate, method of manufacturing the same and use thereof |
| 06/22/2011 | CN101084885B Two sustained-release preparations containing cinnamic acid for preventing coxsackie virus and preparation technology thereof |
| 06/22/2011 | CN101002825B Method for preparing Duzhong soft capsule rich in alpha-linolenic acid and effective component of bark of eucommia |
| 06/22/2011 | CN101001857B 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones |
| 06/21/2011 | USRE42477 Carboxylic acid derivatives, their preparation and use |
| 06/21/2011 | US7964753 Formoterol tartrate process and polymorph |
| 06/21/2011 | US7964646 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 06/21/2011 | US7964564 Chimeric natriuretic peptides |
| 06/21/2011 | US7964555 Contacting cardiac muscle cells with a neuregulin protein to activate the MAP kinase pathway in cardiac muscle cells and induce remodeling of cardiac muscle cell sarcomeric and cytoskeleton structures or cell-cell adhesions |
| 06/21/2011 | US7964220 Method for treating a mammal by administration of a compound having the ability to release CO |
| 06/21/2011 | CA2591314C Novel pyrrolo[3,2-d]pyrimidin-4-one derivatives and their use in therapy |
| 06/21/2011 | CA2563000C Indene derivatives and process for the preparation thereof |
| 06/21/2011 | CA2553918C Pharmaceutical composition for promoting angiogenesis |
| 06/21/2011 | CA2546064C Percutaneous absorption type cerebral protective agent |
| 06/21/2011 | CA2486336C Pentafluorosulfanylbenzoylguanidines, process for their preparation, their use as medicament or diagnostic aid, and medicament comprising them |
| 06/21/2011 | CA2474192C Nicotinamide derivates useful as p38 inhibitors |
| 06/21/2011 | CA2473468C Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes |
| 06/21/2011 | CA2472341C Phosphorus-containing compounds & uses thereof |
| 06/21/2011 | CA2472188C Polymeric gel system for the controlled delivery of codrugs |
| 06/21/2011 | CA2359115C Acyl derivatives which treat vla-4 related disorders |
| 06/21/2011 | CA2355347C Pharmaceutical compositions comprising quinapril magnesium |
| 06/21/2011 | CA2340328C Stable hypoxia inducible factor-1 alpha and method of use |
| 06/21/2011 | CA2299442C Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions |
| 06/21/2011 | CA2199474C Inhibitory or blocking agents of molecular generating and/or inducing functions |
| 06/16/2011 | WO2011072275A2 Agents and methods for treating ischemic and other diseases |
| 06/16/2011 | WO2011072119A2 Stem-cell material and method of use |
| 06/16/2011 | WO2011071716A1 Heterocyclic compounds containing an indole core |
| 06/16/2011 | WO2011071118A1 Agent for promoting differentiation of pluripotent stem cells into cardiac muscle cells which includes nitrovin |
| 06/16/2011 | WO2011071095A1 Benzamide compound |
| 06/16/2011 | WO2011071027A1 Rna interference molecule capable of inhibiting expression of socs3 protein encoded by socs3 gene, and use thereof |
| 06/16/2011 | WO2011070541A1 Cysteine protease inhibitors |
| 06/16/2011 | WO2011070539A1 Cysteine protease inhibitors |
| 06/16/2011 | WO2011069326A1 Bilayer tablet comprising atenolol and amlodipine |
| 06/16/2011 | WO2011048616A3 Healthy sugar and process for preparation of the same |
| 06/16/2011 | WO2011047770A3 Pyrazolopyrimidine derivatives |
| 06/16/2011 | WO2011016652A3 Composition for controlling anal fistulae and method for preparing same |
| 06/16/2011 | WO2011011388A3 Neuregulin induced regeneraton of heart muscle muscle |
| 06/16/2011 | WO2010136900A3 Methods of using krill oil to treat risk factors for metabolic disorders and obesity |
| 06/16/2011 | WO2010117860A3 Microrna signature to predict prognosis in heart failure |
| 06/16/2011 | US20110144577 Hydrophilic coatings with tunable composition for drug coated balloon |
| 06/16/2011 | US20110144320 N-pyrazole a2a receptor agonists |
| 06/16/2011 | US20110144205 Blood Glutathione as a Biomarker for Screening Asymptomatic Patients at Risk for Heart Failure |
| 06/16/2011 | US20110144204 Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same |